These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3786923)

  • 41. [Monochemotherapy of epidermoid lung cancer].
    Dudareva LA; Bidiak IV
    Vopr Onkol; 1987; 33(11):93. PubMed ID: 3686933
    [No Abstract]   [Full Text] [Related]  

  • 42. Surgery and chemotherapy. A new method of treatment for squamous cell bronchial carcinoma.
    Raut Y; Huu N; Clavier J; Guillerm D; Barra JA
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):754-7. PubMed ID: 6208433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical study of the secondary toxicity, effective responses and survival time in the treatment of primary non-microcytic (NSCLC) carcinoma of the lung with various polychemotherapy regimens].
    Carminati F; Maccone C; De Marinis F
    Clin Ter; 1982 May; 101(3):221-7. PubMed ID: 6284434
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chemotherapy of bronchogenic cancer (author's transl)].
    Schmidt CG
    Langenbecks Arch Chir; 1981; 355():123-5. PubMed ID: 6279988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 46. [Primary carcinomas of the lung. Further observations on the antiblastic chemotherapy of inoperable forms].
    Buscioni-Francalanci G; Balatresi P; Piegaia G
    Minerva Chir; 1966 Feb; 21(3):81-92. PubMed ID: 5931210
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chemotherapy of non-small cell bronchial carcinoma].
    Kokron O
    Onkologie; 1984 Oct; 7(5):285-8. PubMed ID: 6392968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Results of synchronizing chemotherapy in bronchogenic carcinoma].
    Grassi GG; Pozzi E
    G Ital Chemioter; 1976; 23(1):55-62. PubMed ID: 801001
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
    Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methotrexate in the chemotherapy of lung cancer.
    Smyth JF; Ford HT
    Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Combined chemotherapy-radiotherapy study of small cell bronchial carcinoma: chemo-/radiotherapy vs radio-/chemotherapy].
    Heilmann HP; Arnal ML; Bünemann H; Calavrezos A; Engel J; Franke HD; Hain E; Jüngst G; Kohl FV; Koschel G; Seysen U; von Wichert P
    Strahlentherapie; 1983 Mar; 159(3):152-5. PubMed ID: 6301110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Spirazidin in the complex treatment of lung cancer].
    Shkrob OS; Zharikov AA
    Khirurgiia (Mosk); 1970 Aug; 46(8):17-22. PubMed ID: 5473666
    [No Abstract]   [Full Text] [Related]  

  • 53. Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma.
    Kane RC; Cohen MH; Broder LE; Bull MI; Creaven PJ; Fossieck BE
    Cancer Chemother Rep; 1975; 59(6):1171-2. PubMed ID: 1222395
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
    Brunner KW; Marthaler T; Müller W
    Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
    [No Abstract]   [Full Text] [Related]  

  • 55. Advanced epidermoid lung cancer: prolonged survival after chemotherapy.
    Richards F; Cooper MR; White DR; Muss HB; Jackson DV; Stuart JJ; Spurr CL
    Cancer; 1980 Jul; 46(1):34-7. PubMed ID: 7388765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Investigation on the complications in bronchial artery infusion with chemotherapeutic agent to treat bronchogenic carcinoma].
    Qian MS
    Zhonghua Fang She Xue Za Zhi; 1989 Jun; 23(3):143-5. PubMed ID: 2582903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An evaluation of combination chemotherapy with procarbazine (NSC-77213) and 5-fluorouracil (NSC-19893) in advanced carcinoma of the lung.
    Gottlieb JA; Serpick AA
    Cancer Chemother Rep; 1970 Oct; 54(5):369-71. PubMed ID: 5514626
    [No Abstract]   [Full Text] [Related]  

  • 58. [Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer].
    Schalhorn A
    Fortschr Med; 1985 May; 103(17):453-6. PubMed ID: 4039699
    [No Abstract]   [Full Text] [Related]  

  • 59. [Drug therapy in bronchial carcinoma].
    Manegold C; Drings P
    Schweiz Med Wochenschr; 1995 Jul; 125(29):1396-405. PubMed ID: 7545824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.